SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-22-000790
Filing Date
2022-04-21
Accepted
2022-04-21 16:21:25
Documents
8

Document Format Files

Seq Description Document Type Size
1 c103581_defa14a.htm DEFA14A 1804297
2 GRAPHIC x1_c103581x2x1.jpg GRAPHIC 345690
3 GRAPHIC x1_c103581x3x1.jpg GRAPHIC 466442
4 GRAPHIC x1_c103581x4x1.jpg GRAPHIC 356173
5 GRAPHIC x1_c103581x81x1.jpg GRAPHIC 90197
6 GRAPHIC x1_c103581x151x1.jpg GRAPHIC 131775
7 GRAPHIC x1_c103581x152x1.jpg GRAPHIC 319327
8 GRAPHIC x1_c103581x153x1.jpg GRAPHIC 109296
  Complete submission text file 0000930413-22-000790.txt   4311626
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 22841696
SIC: 2834 Pharmaceutical Preparations